Asta Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of mass spectrometry equipment. The Company is mainly engaged in the manufacture and sale of matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) based mass spectrometers and related consumables, which are mainly applied in display, secondary battery, and semiconductor industries.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

End-of-day quote Korea S.E. 24/03/2026			5-day change	1st Jan Change
6,070.00 ^KRW	-2.57%		-.--%	-26.60%

23/03	Asta wins 441 million won order	RE
24/02	ASTA Corporation announced that it expects to receive KRW 6 billion in funding from Samsung Securities Co.,Ltd., BOOKOOK Securities Co., Ltd., JB Woori Capital Co., Ltd.	CI

Market Cap	80.69B 108,588B 69.39B 65.48B 59.65B 112B 7,715B 113B 780B 300B 3,913B 303B 296B 12,429B	P/E 2021	-15.4x	P/E 2022	-17.8x
Enterprise Value	77.96B 104,919B 67.05B 63.26B 57.63B 108B 7,454B 109B 753B 290B 3,781B 293B 286B 12,009B	EV / Sales 2021	21.1x	EV / Sales 2022	14.4x
Free-Float	54.42%	Yield 2021 *	-	Yield 2022	-

23/03	Asta wins 441 million won order	RE
24/02	ASTA Corporation announced that it expects to receive KRW 6 billion in funding from Samsung Securities Co.,Ltd., BOOKOOK Securities Co., Ltd., JB Woori Capital Co., Ltd.	CI
24/02	ASTA Corporation announced that it has received KRW 10.464 billion in funding from SD Biosensor, Inc.	CI
10/02	ASTA Corporation announced that it expects to receive KRW 10.464 billion in funding from SD Biosensor, Inc.	CI
10/02	SD Biosensor, Inc. entered into a Share Purchase Agreement to acquire 27.19% stake in ASTA Corporation from Cho Eung-jun and Kim Yang-sun for KRW 32.8 billion.	CI
29/12	ASTA Corporation announced that it has received KRW 2.000664 billion in funding from Robots And Design Co., Ltd.	CI
19/12	ASTA Corporation announced that it expects to receive KRW 2.000664 billion in funding from Robots And Design Co., Ltd.	CI
30/09/25	ASTA Corporation announced that it has received KRW 2.0000304 billion in funding	CI
12/08/25	ASTA Corporation announced that it expects to receive KRW 2.0000304 billion in funding	CI
30/06/25	ASTA Corporation announced that it has received KRW 2.700036 billion in funding from KB Securities Co., Ltd.	CI
20/06/25	ASTA Corporation announced that it expects to receive KRW 2.700036 billion in funding	CI
10/03/25	ASTA Corporation announced that it has received KRW 3 billion in funding	CI
06/03/25	ASTA Corporation announced that it expects to receive KRW 3 billion in funding	CI

1 day	-2.57%
6 months	-17.41%
Current year	-26.60%

ASTA Corporation Stock

Stocks

A246720

KR7246720007

Medical Equipment, Supplies & Distribution

Valuation : ASTA Corporation

Chart: ASTA Corporation

Latest news : ASTA Corporation

Quotes and Performance

Price Extremes

Managers and Directors : ASTA Corporation

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Current year	5,900	11,080
1 year	5,900	11,080
3 years	3,810	12,120
5 years	3,060	13,050
10 years	2,780	29,500

Manager	Title	Age	Since
Eung-Jun Cho CEO	Chief Executive Officer	72	01/01/2006
Jong-Wan Park DFI	Director of Finance/CFO	56	01/11/2018
Yang-Sun Kim CEO	Chief Executive Officer	68	01/01/2006

Director	Title	Age	Since
Eung-Jun Cho CHM	Chairman	72	-
Eung-Soo Cho BRD	Director/Board Member	71	01/12/2015
Chul-Woo Park BRD	Director/Board Member	73	29/03/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ASTA CORPORATION	-2.57%	-.--%	+0.66%	-30.23%	73.89M
ABBOTT LABORATORIES	-1.56%	-5.97%	-23.21%	-0.58%	179B
MEDTRONIC PLC	-1.34%	-3.82%	-3.90%	+11.27%	117B
CENCORA, INC.	-0.68%	-3.64%	+5.31%	+79.42%	61.25B
HOYA CORPORATION	-1.92%	-7.24%	+9.51%	+41.28%	50.24B
BECTON, DICKINSON AND COMPANY	-0.43%	-4.89%	-7.79%	-34.24%	48.05B
DEXCOM, INC.	-1.56%	-5.44%	+9.37%	-22.53%	31.89B
MEDLINE INC.	-0.82%	-11.92%	-	-	28.42B
WEST PHARMACEUTICAL SERVICES, INC.	+1.03%	+2.34%	+31.91%	-12.40%	24.23B
TERUMO CORPORATION	+0.49%	-8.98%	-13.28%	+5.27%	21.4B
Average	-0.97%	-5.78%	+0.95%	+4.14%	56.16B
Weighted average by Cap.	-1.16%	-4.24%	-6.36%	+10.51%

	2021	2022
Net sales	2.56B 3,450B 2.21B 2.08B 1.9B 3.54B 245B 3.58B 24.78B 9.54B 124B 9.63B 9.42B 395B	3.35B 4,502B 2.88B 2.71B 2.47B 4.62B 320B 4.66B 32.33B 12.44B 162B 12.56B 12.29B 515B
Net income	-3.53B -4,753B -3.04B -2.87B -2.61B -4.88B -338B -4.93B -34.13B -13.14B -171B -13.26B -12.97B -544B	-2.8B -3,767B -2.41B -2.27B -2.07B -3.87B -268B -3.9B -27.05B -10.41B -136B -10.51B -10.28B -431B
Net Debt	-5.5B -7,402B -4.73B -4.46B -4.07B -7.6B -526B -7.67B -53.15B -20.46B -267B -20.66B -20.2B -847B	-2.73B -3,669B -2.34B -2.21B -2.02B -3.77B -261B -3.8B -26.35B -10.14B -132B -10.24B -10.01B -420B